Fortive D&A increased by 12.7% to $20.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.4%, from $16.80M to $20.40M. Over 4 years (FY 2021 to FY 2025), D&A shows relatively stable performance with a -1.6% CAGR.
Higher levels indicate significant capital investment in infrastructure or acquisitions, while lower levels may suggest aging assets or limited capital expenditure.
This represents the non-cash expense allocated to the cost of tangible and intangible assets over their useful lives. Be...
High in capital-intensive industries like manufacturing and healthcare devices; lower in service-based sectors.
depreciation_and_amortization_cf| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.20M | $18.40M | $18.60M | $21.50M | $20.40M | $19.70M | $21.90M | $20.40M | $21.70M | $21.80M | $0.00 | $23.10M | $23.10M | $0.00 | $15.90M | $16.80M | $30.90M | $4.30M | $18.10M | $20.40M |
| QoQ Change | — | +1.1% | +1.1% | +15.6% | -5.1% | -3.4% | +11.2% | -6.8% | +6.4% | +0.5% | -100.0% | — | +0.0% | -100.0% | — | +5.7% | +83.9% | -86.1% | +320.9% | +12.7% |
| YoY Change | — | — | — | — | +12.1% | +7.1% | +17.7% | -5.1% | +6.4% | +10.7% | -100.0% | +13.2% | +6.5% | -100.0% | — | -27.3% | +33.8% | — | +13.8% | +21.4% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Intelligent Operating Solutions | $57.10M | $57.60M | $56.80M | $58.20M | $58.40M | $59.10M | $60.50M | $62.40M |
| Advanced Healthcare Solutions | $50.40M | $49.90M | $50.80M | $49.50M | $50.40M | $49.60M | $50.40M | $50.80M |
| Unallocated Corporate Costs and Other | — | — | — | $300.00K | $300.00K | $400.00K | $400.00K | $400.00K |
| Total | $23.10M | $0.00 | $15.90M | $16.80M | $30.90M | $4.30M | $18.10M | $20.40M |